Sort by
Chapter 8 - Combination of virulence and antibiotic resistance: a successful bacterial strategy to survive under hostile environments

Bacterial pathogens have coevolved with the human host for millions of years. During the course of evolution, the bacterial pathogens have adapted to escape the immunological defense responses of the host and to sustain and survive the action of various antibiotics. The widespread use of antibiotics and the host defense system creates a hostile environment for bacteria during their infection and proliferation stages. Bacteria that are either virulent or multidrug-resistant can fight with one of the two onslaughts, either the host defense or the treatment with antibiotics. The development of antibiotic resistance in bacterial species often results in a fitness cost and mutations associated with it may disrupt essential biological functions. Microbes have developed ways to mitigate this hostile situation in unconventional ways via combining the virulence and resistance mechanisms overcoming the evolutionary trade-offs and compensating for the fitness cost. Bacteria employ mechanisms such as hypermutation, compensatory mutations, cross coselection, antibiotic tolerance and persistence in maintaining antibiotic resistance by offsetting the fitness costs. Such strains are widespread among human infections resulting in huge direct medical costs, morbidity, and causing social distress. In this chapter, the authors discuss the interplay between virulence and resistance with respect to the presented mechanisms in providing an added advantage to bacterial pathogens to adapt in different environments, particularly the infective environment. The biological factors and mechanisms that influence the successful association of resistance and virulence mechanisms are described herein, with accompanying examples for specific virulence and resistance factors in several pathogens. Systematic understanding of mechanisms in bacterial pathogens related to their survival strategies will help direct research toward better treatment and prevention strategies.

Relevant
Chapter 2 - Modulation of host pathways by Mycobacterium tuberculosis for survival

Mycobacterium tuberculosis (Mtb) is an extremely pathogenic bacterium which is responsible for causing tuberculosis. M. tuberculosis generally causes infection in lungs and other organs, can survive different physiological conditions inside the host and can also cause latent infection. Mtb, for its survival and pathogenesis, has to modulate various host pathways. The common pathways that are altered by Mtb include modulation of glycolytic flux, endoplasmic reticulum (EPR) stress, mitochondrial metabolism, apoptosis, and necrosis, inhibition of phagosome maturation and autophagy. Mtb harbors various mechanisms to evade host defense pathways for its survival. There are several types of antiinflammatory microRNA-21 which can help in cadence of glycolytic flux and also regulate the levels of phosphofructokinase by decreasing the biosynthetic precursors which are required for inflammatory responses. Further, the EPR stress pathway can be modulated by Mtb with the help of unfolded protein response–inducible transcription factor C/EBP homologous protein. The necrosis is regulated by inhibiting reactive oxygen species (ROS) production with the help of prostaglandin E2. With the help of extracellular regulated kinase 1/2, signal transducer and activator of transcription 3, and mitogen-activated protein kinase p38, interleukin -10 executes apoptosis pathway. Further, autophagy modulation synthesizes phenolic glycolipid with the help of polyketide synthase, encoded by intact pks 1–15 and by manipulating Ca2+ signaling.

Relevant
Chapter 9 - Mechanisms of biofilm-based antibiotic resistance and tolerance in Mycobacterium tuberculosis

Mycobacterium tuberculosis is foremost public health issues globally, and the emergence of multidrug resistance (MDR) and extensively drug resistance tuberculosis (XDR-TB) has further worsened the situation. Eradication of tuberculosis (TB) has become increasingly difficult due to the acquisition of the remarkable intrinsic mechanisms by M. tuberculosis to counter most of the antibiotics. In addition, adaptive antibiotic resistance in M. tuberculosis is recently characterized mechanisms, which include biofilm-mediated resistance and formation of drug-tolerant persister cells and are responsible for relapse cases of infection. Biofilms are formed by a spectrum of pathogenic microorganisms, and provide a means for these organisms to guard themselves against antimicrobial agents. Bacterial biofilms are the basis of several diseases and mainly attributed to the increased antibiotic resistance unveiled by the microbial communities within the biofilm. The resistance in M. tuberculosis is multifactorial, there are several drug resistance mechanisms exist that act together in order to provide an increased level of resistance to biofilm communities. These mechanisms are based on wild type genes and are not the result of mutations. This chapter summarizes both historical and current scientific data in support of the known biofilm-based resistance and tolerance mechanisms in M. tuberculosis, that can further explore in clinical settings.

Relevant
Chapter 10 - Biofilms: cities of microorganisms

Microbial biofilm is defined as a group of microorganisms adhered to an animate or inanimate surface through a self-produced exocytosed polymeric substance. The inability of the antimicrobial components to infiltrate the composite biofilm grid or to the make-up of the bacterial arrangement inside the biofilm helps in protecting the microorganisms. Biofilms can protect microorganisms from extremities: high temperature, pH, high saltiness, high pressure, scarcity of nutrients, antibiotics, etc. as a “protective covering.” In an ecological biome, establishment of biofilms has a crucial role in microbial persistence. Biofilms create challenges in manufacturing sectors like water, energy, food, and medicine, as they build up on the food itself and food-processing equipment, contaminating water channels, corroding submerged metal surfaces, and persisting on medical use devices. Biofilm can boost resistance to host protection systems and are projected for implicating persistent infections, surging healthcare expenses, inpatient care rates, sickness, and deaths. Biofilm-related ailments consist of chronic otitis, periodontitis, respiratory diseases, and chronic wound infections. Bacterial cells inhabiting in the interior of a biofilm are resilient to antibiotics, enduring up to 100–1000 fold better than individual cells. The microbiota inhabiting the human gut creates an intricated-interdependent collaboration with epithelial and immune cells of the gastrointestinal tract (GIT). During the course of collaboration, the microbiota provides nourishment, establishes an initial line of security countering invasion by pathogenic organisms, modulating epithelial growth and immune retaliation. When bacterial cells shift to the biofilm mode of growth, it undergoes a phenotypic modification in behavior in which hefty number of genes are differentially regulated. In this chapter, the regulation of certain genes leading to formation of biofilms by different microorganisms is discussed.

Relevant